115 related articles for article (PubMed ID: 30222967)
21. Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation.
Liangpunsakul S; Wou SE; Zeng Y; Ross RA; Jayaram HN; Crabb DW
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1173-81. PubMed ID: 18832448
[TBL] [Abstract][Full Text] [Related]
22. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer.
Liu S; Miao Y; Fan C; Liu Y; Yu J; Zhang Y; Dai S; Wang E
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):334-40. PubMed ID: 23235348
[TBL] [Abstract][Full Text] [Related]
24. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
25. The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines.
Mack HI; Munger K
Virology; 2013 Nov; 446(1-2):9-16. PubMed ID: 24074562
[TBL] [Abstract][Full Text] [Related]
26. WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.
Richer AL; Cala JM; O'Brien K; Carson VM; Inge LJ; Whitsett TG
Cancer Res; 2017 Sep; 77(17):4663-4672. PubMed ID: 28652249
[TBL] [Abstract][Full Text] [Related]
27. Energy sensing and cancer: LKB1 function and lessons learnt from Peutz-Jeghers syndrome.
Shorning BY; Clarke AR
Semin Cell Dev Biol; 2016 Apr; 52():21-9. PubMed ID: 26877140
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
29. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.
Algire C; Amrein L; Bazile M; David S; Zakikhani M; Pollak M
Oncogene; 2011 Mar; 30(10):1174-82. PubMed ID: 21102522
[TBL] [Abstract][Full Text] [Related]
30. LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.
Wang YS; Chen J; Cui F; Wang H; Wang S; Hang W; Zeng Q; Quan CS; Zhai YX; Wang JW; Shen XF; Jian YP; Zhao RX; Werle KD; Cui R; Liang J; Li YL; Xu ZX
Oncotarget; 2016 Nov; 7(45):73389-73401. PubMed ID: 27705915
[TBL] [Abstract][Full Text] [Related]
31. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
[TBL] [Abstract][Full Text] [Related]
32. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of tumor suppression by LKB1.
Vaahtomeri K; Mäkelä TP
FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
[TBL] [Abstract][Full Text] [Related]
34. The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression.
Cao Y; Li H; Liu H; Zheng C; Ji H; Liu X
Cell Res; 2010 Jan; 20(1):99-108. PubMed ID: 20029389
[TBL] [Abstract][Full Text] [Related]
35. Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.
Chen J; Adikari M; Pallai R; Parekh HK; Simpkins H
Cancer Chemother Pharmacol; 2008 May; 61(6):979-87. PubMed ID: 17661040
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
37. Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin.
Hirano G; Izumi H; Yasuniwa Y; Shimajiri S; Ke-Yong W; Sasagiri Y; Kusaba H; Matsumoto K; Hasegawa T; Akimoto M; Akashi K; Kohno K
Int J Oncol; 2011 Apr; 38(4):893-902. PubMed ID: 21308351
[TBL] [Abstract][Full Text] [Related]
38. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
39. Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach.
Caiola E; Falcetta F; Giordano S; Marabese M; Garassino MC; Broggini M; Pastorelli R; Brunelli L
J Exp Clin Cancer Res; 2018 Dec; 37(1):302. PubMed ID: 30514331
[TBL] [Abstract][Full Text] [Related]
40. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
Tiainen M; Ylikorkala A; Mäkelä TP
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
